Paola Bonaventura, project leader at ErVaccine Technologies, has been giving a talk entitled “Human Endogenous Retrovirus (HERVs) Represent a Source of Shared Tumour Epitopes Inducing High Avidity Cytotoxic T cells for Cancer Immunotherapy” at Neoantigen Based Therapies Summit 2022 (7th annual, Oct 24-26, 2022) in Boston.
For more information visit: https://neo-antigen.com